Stress studies on acyclovir

Journal of Chromatographic Science

Volumn 45, Issue 6, 2007, Pages 319-324

  Sinha, V R ^a   Monika, ^a   Trehan, A ^a   Kumar, Manoj ^a   Singh, S ^b   Bhinge, J R ^a,c  

^a PANJAB UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES; HERPESVIRIDAE;

EID: 34347377127     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/45.6.319     Document Type: Article

References (31)

1. B. Kommanaboyina and C.T. Rhodes. Trends in stability testing,with emphasis on stability during distribution and storage. Drug Dev. Ind. Pharm. 25: 857-68 (1999).
2. B.R. Matthews. Regulatory aspects of stability testing in Europe. Drug Dev. Ind. Pharm. 25: 831-56 (1999).
3. International Conference on Harmonization. Stability testing of new drug substances and products. International Conference on Harmonization, IFPMA, Geneva, Switzerland, 2003.
4. International Conference on Harmonization. Stability testing: Photostability testing of new drug substances and products. International Conference on Harmonization, IFPMA, Geneva, Switzerland, 1996.
5. P.G. Hayden. Antimicrobial Agents: Antiviral Agents, 10th ed. A.G. Gilman, J.G. Hardman, and L.E. Limbird, Eds. Mc Graw-Hill, New York, NY, 2001, pp. 1315-20.
6. T.K. Sia, L. Wulandari, and G. Indrayanto. TLC determination of acyclovir in pharmaceutical preparations and validation of the method used. J. Planar Chromatogr.-Modern TLC. 15: 42-45 (2002).
7. D. Vasilescu and D. Nicolescu. Studies on physicochemical control test developments on a finished product, Acyclovir Tablets-Terapia SA. Rom. Farmacia. 44: 7-8 (1996).
8. K. Basavaiah, H.C. Prameela, and U. Chandrasekhar. Simple high-performance liquid chromatographic method for the determination of acyclovir in pharmaceuticals. Farmaco 58: 1301-1306 (2003).
9. L.S. Nielsen, L.S. Helledi, and L. Schubert. Release kinetics of acyclovir from a suspension of acyclovir incorporated in a cubic phase delivery system. Drug Dev. Ind. Pharm. 27: 1073-81 (2001).
10. E. Lipka-Belloli, V. Glacon, G. Mackenzie, D. Ewing, C. Len, C. Vaccher, and J.P. Bonte. Determination of enantiomeric purity of nucleoside analogs, related to d4T and acyclovir new potential antiviral agents, using HPLC on cellulose chiral stationary phases. J. Chromatogr. A 972: 211-19 (2002).
11. A.L. Huidobro, F.J. Ruperez, and C. Barbas. LC methods for acyclovir and related impurities determination. J. Pharm. Biomed. Anal. 37: 687-94 (2005).
12. P.D. Tzanavaras and D.G. Themelis. High-throughput HPLC assay of acyclovir and its major impurity guanine using a monolithic column and a flow gradient approach. J. Pharm. Biomed. Anal. (2006) In press.
13. D. Zhu and J. Huang. Determination of acyclovir in eye drops by RP-HPLC. Guangdong Yaoxueyan Xuebao. 16: 313-14 (2000).
14. Y. Lei, Y. Liu, X. Li, and C. Shen. Determination of acyclovir in its eye gel by HPLC. Zhonggu Yiyuan Yaoxue Zazhi. 23: 30-31 (2003).
15. N.A. Epshtein. A new approach to HPLC analysis of medicinal suspension. Pharm. Chem. J. 35: 686-89 (2001).
16. I.A. Darwish, A.S. Khedr, H.F. Askal, and R.M. Mahmoud. Simple fluorimetric method for determination of certain antiviral drugs via their oxidation with cerium (IV). Farmaco 60: 555-62 (2005).
17. S.D. Brown, C.A.White, C.K. Chu, and M.G. Barlett. Determination of acyclovir in maternal plasma by high-performance liquid chromatography. J. Chromatogr. B. Biomed. Sci. Appl. 772: 327-34 (2002).
18. A. Loregian, R. Gatti, G. Palu, and E.F. De Palo. Separation methods for acyclovir and related antiviral compounds. J. Chromatogr. B Biomed. Sci. Appl. 764: 289-311 (2001).
19. R.A. Bangaru, Y.K. Bansal, A.R. Rao, and T.P. Gandhi. Rapid, simple and sensitive high-performance liquid chromatographic method for detection and determination of acyclovir in human plasma and its use in bioavailability studies. J. Chromatogr. B Biomed. Sci. Appl. 739: 231-37 (2000).
20. M. Tsuchie, S. Hara, M. Kimura, M. Fuji, N. Ono, and M. Kai. Determination of anti-virus drug, ganciclovir, in human serum by HPLC with precolumn fluorescence derivatization using phenylglyoxal. Anal. Sci. 17: 811-14 (2001).
21. K.K. Peh and K.H. Yuen. Simple high-performance liquid chromatographic method for the determination of acyclovir in human plasma using fluorescence detection. J. Chromatogr. B Biomed. Sci. Appl. 693: 241-14 (1997).
22. J. Salamoun, V. Sprta, T. Sladek, and M. Smrz. Determination of acyclovir in plasma by column liquid chromatography with fluorescence detection. J. Chromatogr. 420: 197-202 (1987).
23. M.M. Caamano, L.V. Garcia, B. Elorza, and J.R. Chantres. Improved RPLC determination of acyclovir using hexylamine as silanol masking agent. J. Pharm. Biomed. Anal. 21: 619-24 (1999).
24. S.S. Zhang, H.X. Liu, Y. Chen, and Z.B. Yuan. Comparison of high performance capillary electrophoresis and liquid chromatography for the determination of acyclovir and guanine in pharmaceuticals and urine. Biomed. Chromatogr. 10: 256-57 (1996).
25. S.D. Brown, C.A. White, and M.G. Barlett. Hydrophilic interaction liquid chromatography/electrospray mass spectrometry determination of acyclovir in pregnant rat plasma and tissue. Rapid Commun. Mass Spectrom. 16: 1871-76 (2002).
26. S.M. Tadepalli and R.P. Quinn. Scintillation proximity radioimmunoassay for the measurement of acyclovir. J. Pharm. Biomed. Anal. 15: 157-63 (1996).
27. S. Singh and M. Bakshi. Guidance on conduct of stress tests to determine inherent stability of drugs. Pharm. Technol. 24: 1-14 (2000).
28. D. Marini, G. Pollino, and F. Balestrieri. Liquid chromatographic determination of acyclovir. Boll. Chim. Farm. 130: 101-104 (1991).
29. M. Bakshi, B. Singh, A. Singh, and S. Singh. The ICH guidance in practice: stress degradation studies on ornidazole and development of validated stability-indicating assay. J. Pharm. Biomed. Anal. 26: 891-97 (2001).
30. D. Marini, G. Pollino, and F. Balestrieri. Liquid chromatographic determination of acyclovir. Boll. Chim. Farm. 130: 101-104 (1991).
31. M. Bakshi, B. Singh, A. Singh, and S. Singh. The ICH guidance in practice: stress degradation studies on ornidazole and development of validated stability-indicating assay. J. Pharm. Biomed. Anal. 26: 891-97 (2001).